Femara (letrozole) - Start Strong

FOR NON US HEALTHCARE PROFESSIONALS ONLY FOR U.S. RESIDENTS NOVARTIS ONCOLOGY

Learn More About Adjuvant Therapy Click here for more

CLINICAL TRIAL IN FIRST-LINE TREATMENT OF ADVANCED BREAST CANCER STUDY RESULTS. FEMARA now approved as adjuvant therapy for early breast cancer

RECENT PUBLICATIONS

Crivellari, et al.
Letrozole Compared With Tamoxifen for Elderly Patients with Endocrine-Responsive Early Breast Cancer: The BIG 1-98 Trial
Click here
Journal of Clinical Oncology (April 2008)

Muss, et al.
Efficacy, Toxicity, and Quality of Life in Older Women With Early-Stage Breast Cancer Treated With Letrozole or Placebo After 5 Years of Tamoxifen: NCIC CTG Intergroup Trial MA.17
Click Here
Journal of Clinical Oncology (April 2008)

Gelmon K.
Prescribing Extended Adjuvant Letrozole
Click here
Breast. 2007 October; [Epub 2007 Jun]

Monnier AM.
The Breast International Group 1-98 trial: big results for women with hormone-sensitive early breast cancer
Click here
Expert Rev Anticancer Ther. 2007 May

Femara Mechanism of Action

Femara Mechanism of Action , a short animation on how Femara works.

EXTENDED ADJUVANT THERAPY

For detailed information about Extended Adjuvant Therapy Click here